Results represent participants receiving the 12mg maintenance dose over 68 weeks
Dockery DW, Pope CA III, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG Jr, & Speizer FE (1993) An association between air pollution and mortality in six US cities
This guide examines what tesofensine is and its triple reuptake mechanism, clinical trial results and weight loss efficacy data, complete dosing protocols from research, side effects and cardiovascular safety concerns, comparing tesofensine to semaglutide , tirzepatide , and other weight loss interventions , legal status and availability issues, and whether tesofensine belongs in weight loss peptide stacks
Tirzepatide (Mounjaro, Zepbound) slows gastric emptying and gastrointestinal motility, leading to common side effects like nausea and constipation